These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The design of full agonists for the cortical muscarinic receptor. Saunders J; Freedman SB Trends Pharmacol Sci; 1989 Dec; Suppl():70-5. PubMed ID: 2694527 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity. Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368 [TBL] [Abstract][Full Text] [Related]
15. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343 [TBL] [Abstract][Full Text] [Related]
16. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety. Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803 [TBL] [Abstract][Full Text] [Related]
17. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide. Pigini M; Brasili L Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145 [TBL] [Abstract][Full Text] [Related]
19. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists. Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]